• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Lannett Co Inc

+ Add to Watchlist

LN5:GR

31.741 EUR 0.541 1.73%

As of 09:34:21 ET on 09/18/2014.

Snapshot for Lannett Co Inc (LN5)

Open: 31.290 Day's Range: 31.290 - 31.741 Volume: 0
Previous Close: 31.200 52wk Range: 12.523 - 37.302 1-Yr Rtn: +126.08%

Stock Chart for LN5

No chart data available.
  • LN5:GR 31.741
  • 1D
  • 1M
  • 1Y
31.200
Interactive LN5 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LN5

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 14.7550
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2015) 2.7800
Est. PEG Ratio 0.2367
Market Cap (M EUR) 1,132.66
Shares Outstanding (M) 35.68
30 Day Average Volume 177
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LN5

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LN5

Lannett Company, Inc. manufactures and distributes pharmaceutical products under its own trade name and under generic names. The Company also distributes competitive pharmaceutical products manufactured by other companies. The principal products include antifungals, antacids, dermatological preparations, and analgesic sedatives.

Arthur P BedrosianPresident/CEOWilliam F SchreckChief Operating Officer
Martin P GalvanVP:Finance/CFO/TreasurerRobert EhlingerVP:Logistics/CIO
More Company Profile & Key Executives for LN5

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil